Reagent | Amount for 10 reactions (µl) |
---|---|
PCRBIO Taq 2x polymerase red mix | 125 |
Forward primer 10 µM | 10 |
Reverse primer 10 µM | 10 |
Sterile Distilled Water | 105 |
Total Volume | 250 |
Step | Cycles | Temperature (°C) | Time (s) |
---|---|---|---|
Initial Denaturation | 1 | 95 | 300 |
Denaturation | 35 | 94 | 30 |
Annealing | 35 | 59.5-64.5 (depending on the primer's Tm) | 45 |
Extension | 35 | 72 * | 20 per kilobase |
Final Extension | 1 | 72 | 300 |
Hold | 1 | 4 | ∞ |
*Varies depending on the length of the insert
Reagent | Volume (µl) |
---|---|
Q5 2X Hot Start Master Mix | 12.5 |
Forward primer | 2.5 |
Reverse primer | 2.5 |
Template DNA (conc. 100pg/µl) | 1.0 |
Sterile Distilled Water | 31.5 |
Total Volume | 50 |
(Keep all reagents on ice while producing the mixture)
Step | Cycles | Temperature (°C) | Time (s) |
---|---|---|---|
Initial Denaturation | 1 | 95 | 300 |
Denaturation | 25-35 | 94 | 30 |
Annealing | 25-35 | 59.5-64.5 (depending on the primer's Tm) | 45 |
Extension | 25-35 | 72 | 105 |
Final Extension | 1 | 72 | 300 |
Hold | 1 | 4 | ∞ |
¹www.neb.com. (n.d.). Transformation Protocol | NEB. [online] Available at: https://www.neb.com/en-gb/protocols/2012/05/21/transformation-protocol.
Used this protocol: https://www.neb.com/en-gb/protocols/2018/10/02/golden-gate-assembly-protocol-for-using-neb-golden-gate-assembly-mix-e1601
BL21 LEMO was used as the protein expression strain.
Through the use DH5α cells, we expect to get a high competency with these (at least 1 x 106 per µg DNA). Does not require antibiotics (so be careful to work aseptically)
Reagent | Volume (ml) for 125ml |
---|---|
300mM KAc (autoclaved) | 12.5 |
1M RbCl (filter sterilised) | 12.5 |
100mM CaCl2 (autoclaved) | 12.5 |
500mM CaCl2 (autoclaved) | 12.5 |
glycerol (autoclaved) | 18.5 |
pH to 5.8 with acetic acid then make up to 125ml with sterile H2O and filter sterilise into a sterile bottle. Store at 4°C.
Reagent | Volume (ml) for 50ml |
---|---|
100mM MOPS (autoclaved) | 5.0 |
750mM CaCl2 (autoclaved) | 5.0 |
100mM RbCl (filter sterilised) | 5.0 |
glycerol (autoclaved) | 7.5 |
pH to 6.5 with KOH then make up to 50ml with sterile H2O and filter sterilise into a sterile bottle. Store at 4°C.
For us to characterise the activity of PafA and the variants we created, we decided to utilise PNPP. Phosphatase enzymes can hydrolyse PNPP into inorganic phosphate and pNP, the latter of which is yellow. This crucial property allows us to measure the absorbance at 405nm on a spectrophotometer or plate reader and convert these absorbance values into the concentration of pNP. This enables us to gather information such as Vmax and Km to determine the effect of different conditions on enzyme activity.
Before we conducted the assays we needed to make up reaction buffer for the enzyme and substrate buffer for PNPP which consist of:
Substrate buffer |
---|
100mM Tris HCl pH7.4 |
200mM NaCl |
Reaction Buffer |
---|
100mM Tris |
200mM NaCl |
100µM ZnSO4 |
The starting assay for all of the characterisations was a kinetics assay, which consisted of varying concentrations of PNPP to enable us to create a Michaelis Menten graph to determine the kinetic properties of the enzyme. Figure 1 depicts the process which we went through for each of the kinetics assays. For the variants, we typically used 11.1nM or 111.1 nM of enzymes in the rows.
Figure 1: Stages of Kinetic Assay. Using a 96-well plate, create the appropriate array of chemicals as shown, and using a multichannel pipette, add the contents from Row A to all other rows after closing the lid, and add it to a plate reader, measuring at 30 seconds for 90 minutes.
For pH assays, we used a pH meter to make up PNPP to a variety of different pH’s (sodium acetate (pH 4, 5, 6 and 6.5); Tris/HCl (pH 6.5, 7, 7.5, 8, 8.5, 9, 9.5 and 10)) and pipetted this into row A instead of having a serial dilution of PNPP.
For the temperature assays, we used a hot block at temperatures ranging from 15 to 90°C using the protocol in Figure 2 The stop solution was made up of 1.1M NaOH, 25mM EDTA, 500mM K2PO4.
Figure 2: The stages of pH Assay. This goes through the stages of preheating the constituents, adding the appropriate solution to the enzyme and then measuring the absorbance after the stop solution was added.
For the inhibition assays, we utilised Pi ranging from 5mM to 0.00244mM. We added Pi to the assay and then incorporated PNPP on the top row, utilising a serial dilution. This way each column had a decreasing concentration of Pi to measure the level at which product inhibition occurs. We did 2 plates, the first plate being PafA and PhoA inhibition levels being measured.
The second plate contained the variants; 30.1, 50.2 and 70.2. Each row from B to G contained 20ul of enzyme across the entire plate, A contained the Pi-PNPP-RB mixture and H contained simply just RB to act as a control.